Page last updated: 2024-10-30

loxoprofen and Cardiomyopathies

loxoprofen has been researched along with Cardiomyopathies in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koide, M1
Ito, K1
Taniguchi, T1
Yokoi, H1
Nakamura, R1
Irie, H1
Kinoshita, N1
Hashimoto, T1
Tamaki, S1
Sawada, T1
Azuma, A1
Matsubara, H1

Other Studies

1 other study available for loxoprofen and Cardiomyopathies

ArticleYear
[A case of takotsubo cardiomyopathy provoked by taking a new quinolone antibiotic drug and a non-steroidal anti-inflammatory drug].
    Kaku igaku. The Japanese journal of nuclear medicine, 2006, Volume: 43, Issue:1

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiomyopathies;

2006